Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 265–288 of 385 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Hip Arthrosis Clear all

Conditions: Degenerative Joint Disease
Interventions: R3 Biolox Delta Ceramic Acetabular System; Device
Lead sponsor: Smith & Nephew, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 189 participants
Timeline: 2018 – 2023
U.S. locations: 8
States / cities: Tampa, Florida • Tucker, Georgia • Annapolis, Maryland + 5 more

Conditions: Arthritis, Failure of Total Hip
Interventions: Not listed
Lead sponsor: OrthoCarolina Research Institute, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 174 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip, Chronic Low Back Pain
Interventions: COV155; Drug
Lead sponsor: Mallinckrodt; Industry
Eligibility: 18 Years and older
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 34
States / cities: Anaheim, California • Lomita, California • Santa Ana, California + 24 more

Conditions: Joint Disease
Interventions: total hip arthroplasty implant; Device
Lead sponsor: MicroPort Orthopedics Inc.; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Hip Osteoarthritis
Interventions: MPact Cup; Device
Lead sponsor: Medacta USA; Industry
Eligibility: Not listed
Enrollment: 187 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2022
U.S. locations: 5
States / cities: Parker, Colorado • Boise, Idaho • Libertyville, Illinois + 2 more

Conditions: Osteoarthritis
Interventions: Pain Coping Skills Training (CST); Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Osteoarthritis, Total Hip Arthroplasty
Interventions: LPB, QLB; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 95 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Anemia, Arthritis, Total Knee Arthroplasty, Total Hip Arthroplasty
Interventions: Conventional Oral TXA (Tranexamic Acid), Multi-Dose Oral TXA (Tranexamic Acid); Drug
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Osteoarthritis, Hip
Interventions: Cooled RFA treatment with COOLIEF* device, intra-articular corticosteroid injection; Procedure · Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Pain, Osteoarthritis, Hip, Osteoarthritis, Knee
Interventions: NSAID, Tanezumab 2.5 mg, Tanezumab 5 mg; Drug · Biological
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older
Enrollment: 3,021 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 299
States / cities: Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 187 more

Conditions: Acute Pain, Arthropathy of Knee, Arthropathy of Hip, Pain, Postoperative, Kidney Transplant Donor, Bariatric Surgery Candidate
Interventions: NSS-2 Bridge; Device
Lead sponsor: Jacques E. Chelly; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 3
States / cities: Pittsburgh, Pennsylvania

Conditions: Hip Osteoarthritis, Acute Traumatic Fracture of the Femoral Head or Neck, Avascular Necrosis of the Femoral Head
Interventions: Z1 Femoral Hip System; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 5
States / cities: Platte City, Missouri • Charlotte, North Carolina • Cleveland, Ohio + 2 more

Conditions: Osteoarthritis of Hip
Interventions: No hip precautions; Procedure
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years and older
Enrollment: 321 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Osteoarthritis
Interventions: Not listed
Lead sponsor: Curexo Technology Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Patellofemoral Pain Syndrome
Interventions: Hip Progressive Resistive Exercise, Quad Progressive Resistive Exercises; Other
Lead sponsor: Timothy Uhl; Other
Eligibility: 15 Years to 35 Years · Female only
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Heterotopic Ossification
Interventions: Naproxen, placebo; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 80 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2022
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Degenerative Joint Disease, Osteoarthritis, Hip, Avascular Necrosis of Hip, Traumatic Arthropathy-Hip
Interventions: Hip Innovation Technology Reverse Hip Replacement System, Already-marketed semi-constrained uncemented hip systems using a metal-on-XLPE or ceramic-on-XLPE bearing combination.; Device
Lead sponsor: Hip Innovation Technology; Industry
Eligibility: 50 Years to 75 Years
Enrollment: 288 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2038
U.S. locations: 6
States / cities: Miami, Florida • Tampa, Florida • Baltimore, Maryland + 2 more

Conditions: Osteoarthritis, Hip
Interventions: OMNI Apex Modular™ Hip Device, OMNI Apex ARC™ Hip Device; Device
Lead sponsor: Spokane Joint Replacement Center; Other
Eligibility: 20 Years to 80 Years
Enrollment: 73 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2018
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Osteoarthritis
Interventions: Nonsteroidal anti-inflammatory drugs (NSAIDs), Acetaminophen; Drug
Lead sponsor: Stanford University; Other
Eligibility: 50 Years to 85 Years
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2001
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Osteoarthritis, Hip
Interventions: Lumiracoxib (drug); Drug
Lead sponsor: Novartis; Industry
Eligibility: 40 Years and older
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2004
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Osteoarthritis
Interventions: Metal-on-metal primary total hip arthroplasty (DePuy ); Device
Lead sponsor: Anderson Orthopaedic Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Alexandria, Virginia

Conditions: Osteoarthritis
Interventions: Total hip arthroplasty; Device
Lead sponsor: Anderson Orthopaedic Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 2
States / cities: Boston, Massachusetts • Alexandria, Virginia

Conditions: Total Hip Arthroplasty, Osteoarthritis
Interventions: Functional Strength Integration (FSI), Control Group (CON); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years to 85 Years
Enrollment: 95 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2022
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Degenerative Joint Disease, Osteoarthritis
Interventions: EACA, Placebo arm; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Jacksonville, Florida

Search by objective public record fields.

R3 Delta Ceramic Acetabular System PAS U.S.

A Validated Necrosis Assay to Determine the Need for Revision Surgery in Metal-on-metal Total Hip Arthroplasty

Open Label Safety and Tolerability Study of COV155 in Subjects With Osteoarthritis (OA) or Chronic Low Back Pain (CLBP)

Evaluation of Bone Mineral Density Changes After Total Hip Replacement: A Two-Year Clinical and DXA Analysis

Assess the Mid-term Performance of the Mpact Cup in Subjects Requiring Total Hip Arthroplasty

Pain Coping Skills Training for African Americans With Osteoarthritis

Lumbar Plexus Block Versus Quadratus Lumborum Block for Primary Anterior Total Hip Arthroplasty

Single Versus Multi-Dose Oral Tranexamic Acid in Patients at High Risk for Blood Transfusion After Total Joint Arthroplasty

Use of Cooled Radiofrequency for the Treatment of Hip Pain Associated With Hip OA Compared to Intra-articular Steroid Injections

Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee

NSS-2-BRIDGE Study for Total Knee and Hip Arthroplasties, Bariatric, and Kidney Transplant Surgeries

Z1 Hip System: Post-Market Clinical Follow Up Study

A Study of Posterior Hip Precautions After Total Hip Arthroplasty

ROBODOC® Clinical Trials: Long-Term Follow-Up

Comparing Rehabilitation Programs for Patellofemoral Pain Syndrome

Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy

Safety and Effectiveness of the HIT Reverse HRS

Femoral Remodeling Following Total Hip Arthroplasty With OMNI Apex Modular™ and OMNI Apex ARC™ Stem Compared to Competitive Designs

Toward Better Outcomes in Osteoarthritis

Efficacy and Safety Study of Lumiracoxib in Patients With Primary Hip Osteoarthritis

A Five-Year Metal-on-Metal Retrospective Clinical Study

Analysis of Crosslinked and Conventional Polyethylene Explants

Improving Rehabilitation Outcomes After Total Hip Arthroplasty

Epsilon Aminocaproic Acid (EACA) for the Reduction of Blood Loss in Total Hip Arthroplasty (THA)